Correspondence 0001104659-24-064210 from Orchestra BioMed Holdings, Inc. (OBIO) (CIK 0001814114) (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO) (CIK 0001814114)
Date: May 22, 2024 · CIK: 0001814114 · Accession: 0001104659-24-064210
AI Filing Summary & Sentiment
File numbers found in text: 333-279430
Letter
ORCHESTRA BIOMED HOLDINGS, INC.
150 Union Square Drive
New Hope, Pennsylvania 18938
May 22, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Orchestra BioMed Holdings, Inc.
Registration Statement on Form S-3 filed on May 15,
File No. 333-279430
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Orchestra BioMed Holdings, Inc. (the “Company”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-3 (File No. 333-279430) of the Company, filed with the U.S. Securities and Exchange Commission on May 15, 2024 (the “Registration Statement”), be accelerated so that the Registration Statement shall become effective at 4:00 p.m. (Eastern Time) on May 24, 2024, or as soon as possible thereafter.
The Company hereby confirms that it is aware of its responsibilities under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed offering of the securities specified in the Registration Statement.
It would be appreciated if, promptly after the Registration Statement has become effective, you would so inform our outside counsel, Keith Pisani of Paul Hastings LLP, by telephone at (212) 318-6053 or by email at keithpisani@paulhastings.com. The Company hereby authorizes Mr. Pisani of Paul Hastings LLP to orally modify or withdraw this request for acceleration.
Sincerely
ORCHESTRA BIOMED HOLDINGS, INC.
Show Raw Text
CORRESP
1
filename1.htm
ORCHESTRA
BIOMED HOLDINGS, INC.
150 Union Square Drive
New Hope, Pennsylvania 18938
May 22, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Orchestra BioMed Holdings, Inc.
Registration Statement on Form S-3 filed on May 15,
2024
File No. 333-279430
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Orchestra BioMed Holdings, Inc. (the “Company”) hereby respectfully requests that
the effectiveness of the Registration Statement on Form S-3 (File No. 333-279430) of the Company, filed with the U.S. Securities
and Exchange Commission on May 15, 2024 (the “Registration Statement”), be accelerated so that the Registration
Statement shall become effective at 4:00 p.m. (Eastern Time) on May 24, 2024, or as soon as possible thereafter.
The Company hereby confirms that it is aware of its responsibilities
under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed offering
of the securities specified in the Registration Statement.
It would be appreciated if, promptly after the Registration Statement
has become effective, you would so inform our outside counsel, Keith Pisani of Paul Hastings LLP, by telephone at (212) 318-6053 or by
email at keithpisani@paulhastings.com. The Company hereby authorizes Mr. Pisani of Paul Hastings LLP to orally modify or withdraw
this request for acceleration.
Sincerely
ORCHESTRA BIOMED HOLDINGS, INC.
By:
/s/ Andrew Taylor
Name:
Andrew Taylor
Title:
Chief Financial Officer
cc:
Keith Pisani
Paul Hastings LLP